India's First MRNA COVID Vaccine Candidate Found To Be Safe, Gets DCGI Nod For Phase 2/3 Clinical Tr

[email protected]14 Oct, 2021News

India's first indigenous mRNA Covid-19 vaccine candidate, which is being developed by Pune-based Gennova Biopharmaceuticals Limited, has been found safe, tolerable, and immunogenic in the participants of the phase-1 study. Gennova Biopharmaceuticals had submitted the interim clinical data of the Phase I study of the vaccine to the Central Drugs Standard Control Organisation (CDSCO), which is the Indian drug regulatory authority.